Temat: failure - Katalog OPAC zbiorów

Skocz do pozycji: 1.

Tytuł:: Significance of education and self-management support for patients with chronic heart failure in family physician practice
Autorzy:: Korzh, Oleksii
Krasnokutskiy, Sergiy
Powiązania:: https://bibliotekanauki.pl/articles/551603.pdf
Data publikacji:: 2016
Wydawca:: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
Tematy:: education
heart failure
self-management.
Źródło:: Family Medicine & Primary Care Review; 2016, 4; 432-436
1734-3402
Pojawia się w:: Family Medicine & Primary Care Review
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 2.

Tytuł:: Expression profile of circulating microRNAs in patients with ischemic heart failure with moderately reduced left ventricular ejection fraction – pilot study
Autorzy:: Kaufmann, Damian
Daniłowicz-Szymanowicz, Ludmiła
Sakowicz-Burkiewicz, Monika
Szwoch, Małgorzata
Pawełczyk, Tadeusz
Raczak, Grzegorz
Powiązania:: https://bibliotekanauki.pl/articles/895765.pdf
Data publikacji:: 2019-02-05
Wydawca:: Gdański Uniwersytet Medyczny
Tematy:: heart failure
circulating microRNAs
biomarkers
Opis:: Introduction: Heart failure (HF) is a growing global pandemic that affects millions of people around the world. Despite the progress in medicine, diagnosis and treatment of HF remains problematic. Recently, noncoding micro ribonucleic acids called miRNAs have become significant in the diagnosis and stratification of HF risk. Aim: The aim of this study was the attempt to identify the profile of circulating miRNAs specific for ischemic HF with moderately reduced left ventricular ejection fraction (HFmrEF). Methods and Results: A number of changes in the miRNA profile can characterise patients with ischemic HFmrEF. This is a pilot study before further research on a larger group of patients. Conclusions: Using the quantitative reverse transcription-polymerase chain reaction (qRT-PCR), serum levels of 84 miRNA were measured and compared between a patient with ischemic HFmrEF and a healthy volunteer. Analysis reveals a down-regulation of let-7f-5p and miR-1-3p, as well as up-regulation of miR-100-5p, miR-10b-5p, miR-125a-5p, miR-140-5p, miR-144-3p, miR-149-5p, miR-15b-5p, miR-183-5p, miR-208b-3p, miR-224-5p, miR-26b-5p, miR-27b-3p, miR-302a-3p, miR-320a, miR-7-5p, miR-99a-5p.
Źródło:: European Journal of Translational and Clinical Medicine; 2018, 1, 2; 53-57
2657-3148
2657-3156
Pojawia się w:: European Journal of Translational and Clinical Medicine
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 3.

Tytuł:: Mitral regurgitation and its modern treatments
Autorzy:: Pręgowski, Jerzy
Powiązania:: https://bibliotekanauki.pl/articles/1916655.pdf
Data publikacji:: 2020
Wydawca:: Polska Akademia Nauk. Czytelnia Czasopism PAN
Tematy:: mitral regurgitation
heart failure
percutaneus intervention
Opis:: Mitral regurgitation is the second most common valvular disease. The etiology is either primary or functional-secondary to the left ventricle dysfunction in the course of coronary artery disease, arterial hypertension and diabetes. Along with the population aging and increasing number of comorbidities the number of patients with mitral regurgitation soars. In patients with heart failure the mitral regurgitation significantly decreases the quality of life and worsens the survival prognosis. Surgical correction is the treatment of choice in patients with mitral regurgitation. However, up to 50% of potential candidates are denied surgery for its prohibitive risk. The minimally invasive, percutaneus procedures are potential solution for those subjects. Currently the „edge to edge” technique with use of the MitraClip system is most commonly performed. This procedure is less efficient in MR reduction than open heart surgery. However, the number of periprocedural complications is smaller. It has been shown the MR correction with the MitraClip device improves the duration and quality of life. There are several ongoing preclinical studies on the percutaneusly implanted mitral valve prosthesis. First in men procedures have been performed. However the mitral valve anatomy is much more complex as compared to aortic. Therefore the breakthrough comparable to TAVI procedure will not occur in the very close future.
Źródło:: Nauka; 2020, 3
1231-8515
Pojawia się w:: Nauka
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 4.

Tytuł:: The impact of renal function on clinical and biochemical characteristics in advanced heart failure patients
Autorzy:: Bohdan, Michał
Frankiewicz, Anna
Gruchała, Marcin
Powiązania:: https://bibliotekanauki.pl/articles/895727.pdf
Data publikacji:: 2019-02-05
Wydawca:: Gdański Uniwersytet Medyczny
Tematy:: heart failure
kidney disease
exercise capacity
Opis:: Background: Coexistence of heart failure with reduced ejection fraction (HFrEF) and chronic kidney disease is associated with poor prognosis. We assessed the effect of renal function on exercise capacity and clinical parameters of patients with HF. Material and methods: Forty five patients aged 58.2 ± 10.6 years with stable severe HFrEF were recruited. Patients were divided into 3 groups: group 1 - eGFR: 30-59 ml/min/1.73 m2; group 2 - eGFR: 60-89 ml/min/1.73 m2 and group 3 - eGFR: ≥90 ml/min/1.73 m2. Biochemical analysis, echocardiography, 6-minute walking test and cardiopulmonary stress testing were performed. Results: Patients in group 1 were significantly older than patients in group 3 (60.4 ± 11.1 years vs. 49.25 ± 11.2 years, respectively, p<0.05). Patients in group 2 had significantly higher BMI in comparison to group 3 (29.8 ± 4.4 vs. 25.1 ± 4.2; p<0.05). Interestingly, patients in group 1 had significantly lower peak oxygen uptake (10.2 ± 3.1 ml/kg/min vs. 16.1 ± 3.5 ml/kg/min, p<0.05) and oxygen uptake at anaerobic treshold (7.9 ± 2.4 ml/kg/min vs. 10.7 ± 1.9 ml/kg/min, p<0.05). Conclusions: Diminished renal function in patients with stable, advanced HFrEF may be associated with significantly worse peak VO2 and VO2 in AT.
Źródło:: European Journal of Translational and Clinical Medicine; 2018, 1, 2; 17-22
2657-3148
2657-3156
Pojawia się w:: European Journal of Translational and Clinical Medicine
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 5.

Tytuł:: Risk factors for poor prognosis in heart failure with particular attention to the elderly population
Autorzy:: Dobrowolska, Małgorzata
Miękus, Paweł
Świątczak, Michał
Raczak, Grzegorz
Daniłowicz-Szymanowicz, Ludmiła
Powiązania:: https://bibliotekanauki.pl/articles/1891021.pdf
Data publikacji:: 2021-12-02
Wydawca:: Gdański Uniwersytet Medyczny
Tematy:: heart failure
risk factors
prognosis
elderly
Opis:: Background: Heart failure (HF) is a leading cause of poor outcome. Age is considered one of the most critical risk factors for both the incidence and prognosis of HF. Therefore we aimed to assess the predictors of poor prognosis in HF patients with particular attention to the elderly population. Material and methods: We retrospectively enrolled patients hospitalized due to HF exacerbation during 2016-2017 (203 patients). The end-points were all-cause mortality and emergency rehospitalizations within a two-year follow-up period. A detailed analysis was performed in the subgroups of patients younger and older than 65 years old. Results: 121 (60%) patients experienced the end-points. Age, low systolic blood pressure, NYHA class IV, right ventricle HF symptoms, high C-reactive protein, troponin, NT-proBNP, hyponatremia, catecholamine therapy and mechanical ventilation during hospitalization independently predicted the end-points. The elderly were characterized by a higher incidence of concomitant diseases and HF with moderately reduced or preserved LVEF, worse laboratory parameters and pharmacological treatment, as well as worse prognosis. Conclusion: The prognosis of patients hospitalized due to HF, mainly the elderly, is poor. Simple clinical parameters could be useful in further decision-making regarding the intensification of their treatment.
Źródło:: European Journal of Translational and Clinical Medicine; 2021, 4, 2; 18-30
2657-3148
2657-3156
Pojawia się w:: European Journal of Translational and Clinical Medicine
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 6.

Tytuł:: Cardiooncological balance in a 75-year-old male with a hepatocellular carcinoma CS IV and a congestive heart failure NYHA III „de novo”
Autorzy:: Żechowicz, Maciej
Wroński, Konrad
Rucińska, Monika
Powiązania:: https://bibliotekanauki.pl/articles/1065186.pdf
Data publikacji:: 2015
Wydawca:: Medical Education
Tematy:: cardiooncology
heart failure
hepatocellular carcinoma (HCC)
Opis:: The case reports about a 75-years-old man without a previous medical history, in whom a heart failure NYHA III de novo was diagnosed together with persistent atrial fibrillation and hepatocellular carcinoma in clinical stage IV. Based on echocardiography and computed tomography there were pulmonary hypertension in course of lymphangiosis carcinomatosa as well as diffuse metastases in the abdomen diagnosed. Before the treatment initiation the patient was classified 3 in WHO performance status. After an improvement in control of the rhythm frequency and the heart failure treatment stabilisation with a β-blocker, an ACE-inhibitor, spironolactone and furosemide, the patient’s performance status improved to WHO 2. He was further disqualified from surgical procedures due to the advanced clinical stage of the oncological disease. Considering high probability of further cardiotoxic influence of sorafenib on the heart failure despite its satisfactory control, the patient was assigned to palliative chemotherapy with FOLFOX. Parallel he was strictly followed up cardiologically in an outpatient clinic what certainly supported the oncological treatment. The patient survived 32 weeks from the first hospitalization and the progression free survival was 12 weeks from the chemotherapy initiation.
Źródło:: OncoReview; 2015, 5, 2; A57-61
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 7.

Tytuł:: Cardiac Rehabilitation in Heart Failure. Part I, Mechanism
Autorzy:: Kujawska, Agnieszka
Husejko, Jakub
Marszałek, Agata
Szczęśniak, Żaneta
Topka, Weronika
Gajos, Małgorzata
Androsiuk-Perkowska, Joanna
Perkowski, Radosław
Natalia, Skierkowska
Kujawski, Sławomir
Kędziora-Kornatowska, Kornelia
Powiązania:: https://bibliotekanauki.pl/articles/1030501.pdf
Data publikacji:: 2018
Wydawca:: Uniwersytet Szczeciński. Wydawnictwo Naukowe Uniwersytetu Szczecińskiego
Tematy:: cardiac rehabilitation
exercise training
heart failure
pathophysiology
Opis:: Diagnosis and treatment issues among heart failure (HF) patients are becoming one of the most important points in public health of developed countries, largely due to the aging of population and the fact that HF affects mainly the elderly. In this review we would like to focus on pathophysiology of exercise intolerance in patients with heart failure and potential benefits of cardiac rehabilitation (CR). Analysis of articles in the EBSCO database using keywords: heart failure, cardiac rehabilitation, exercise training, pathophysiology. HF can be described as a composite syndrome which results from structural or functional impairment of ventricular filling or blood ejection. Patients have variety of symptoms which usually are nonspecific. The most frequently occurring symptoms of HF are dyspnea and fatigue, which may restrict exercise capacity, and fluid retention. There are many possible pathophysiological factors involved in the development of exercise intolerance. Based on the available literature pathological changes in central hemodynamic function, pulmonary system, skeletal muscles, endothelial function and neurohumoral system can be distinguished. They play a crucial role in the pathogenesis of HF symptoms and represent a potential curative object. HF patients are characterized by diminished functional performance. Exercise training has many potential profits in patients with heart failure, including an increase in peak oxygen uptake, improvement in central hemodynamics, peripheral vascular and skeletal muscle function and has become part of evidence-based clinical therapy in these patients.
Źródło:: Central European Journal of Sport Sciences and Medicine; 2018, 21, 1; 13-21
2300-9705
2353-2807
Pojawia się w:: Central European Journal of Sport Sciences and Medicine
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 8.

Tytuł:: Health behaviour of elderly patients with heart failure in Poland associated with pharmacotherapy and non-pharmacological treatment
Autorzy:: Makarewicz-Wujec, Magdalena
Janas, Ewelina
Kozłowska-Wojciechowska, Małgorzata
Powiązania:: https://bibliotekanauki.pl/articles/895264.pdf
Data publikacji:: 2019-04-30
Wydawca:: Polskie Towarzystwo Farmaceutyczne
Tematy:: heart failure
health behaviour
adherence
elderly patients
Opis:: Introduction. In Poland, it is estimated that HF is observed in approximately 0,7 million of patients. The aim of the study was to assess health behaviour in geriatric patients diagnosed with HF regarding pharmacotherapy and non-pharmacological treatment. Material and methods. The study group comprised 72 patients with diagnosed HF, over 65y. The study was performed using a questionnaire survey including 20 closed-ended questions. Results. The mean number of medicinal products prescribed by physicians for the treatment of HF and other diseases was 6.59±1.8. 50% of subjects were additionally taking medications and supplements for self-treatment, 63% declared they managed to take medications prescribed on their own. A diet is followed only by 50%, but only 18% limit their sodium intake. 46% still consume alcohol, and 10% of still smoke cigarettes. 46% declared the use of body weight monitoring, but none of them measured their body weight every day. Conclusion. Health behaviour of geriatric patients with HF in Poland indicates their low compliance with medical guidelines and it may explain a high hospitalisation rate and increasing costs of treatment.
Źródło:: Acta Poloniae Pharmaceutica - Drug Research; 2019, 76, 2; 367-374
0001-6837
2353-5288
Pojawia się w:: Acta Poloniae Pharmaceutica - Drug Research
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 9.

Tytuł:: His bundle pacing in patients with permanent atrial fibrillation and heart failure with non-reduced ejection fraction – retrospective study
Autorzy:: Skonieczny, Bartosz
Sławuta, Agnieszka
Radziejewska, Jadwiga
Jagielski, Dariusz
Gajek, Jacek
Kozłowski, Dariusz
Powiązania:: https://bibliotekanauki.pl/articles/24987710.pdf
Data publikacji:: 2024-01-08
Wydawca:: Gdański Uniwersytet Medyczny
Tematy:: heart failure
permanent atrial fibrillation
His bundle pacing
Opis:: Background: Heart failure [HF] constitutes a complex clinical entity and often coexists with atrial fibrillation [AF]. There is scarcity of evidence-based therapies for those with ejection fraction [EF] ≥ 40%. Effect of regularization of ventricular response in patients with HF with EF ≥ 40% and concomitant atrial fibrillation is unknown. Material and methods: This was a retrospective case-series study. 14 patients with symptomatic HF with EF ≥ 40% and permanent atrial fibrillation who had undergone pHBP were identified and enrolled. For 9 patients pHBP was a primary strategy, for the remaining patients it was an upgrade from right ventricular lead. All patients underwent follow-up visit 3 months after the procedure. Results: NYHA class was significantly reduced (mean 2.5 vs. 1.0, p-value < 0.001). Left ventricular ejection fraction significantly increased mean increase 8.5%, 95% CI 7.7–9.2, p < 0.001) Similarly, significant decrease in left ventricular end diastolic diameter was observed (mean decrease 5.4 mm, 95% CI 5.0–5.8 mm, p < 0.001). The degree of mitral regurgitation after three months was lower (mean grade 2.4 vs. 1.2, p < 0.001). At follow-up prescribed doses of beta blocker were higher (mean metoprolol equivalent dose rose by 69.6 mg). Conclusions: Permanent His bundle pacing might be beneficial in the setting of permanent AF and HF with EF ≥ 40%.
Źródło:: European Journal of Translational and Clinical Medicine; 2023, 6, 2; 45-50
2657-3148
2657-3156
Pojawia się w:: European Journal of Translational and Clinical Medicine
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 10.

Tytuł:: Relationship between perceived fear of COVID-19 and self-care management in heart failure patients
Autorzy:: Yeni, Tuğba
Bülbül, Elif
Efil, Sevda
Yıldız-Ayvaz, Meryem
Türen, Sevda
Hiçerimez, Ayfer
Powiązania:: https://bibliotekanauki.pl/articles/40570855.pdf
Data publikacji:: 2024-06-30
Wydawca:: Uniwersytet Rzeszowski. Wydawnictwo Uniwersytetu Rzeszowskiego
Tematy:: COVID-19 fear
heart failure
self-care management
Opis:: Introduction and aim. The fear of contracting COVID-19, which affects human health biopsychosocially, is expected to affect the self-care management of patients with heart failure (HF). This study was conducted to investigate the relationship between perceived fear of COVID-19 and self-care management in HF patients. Material and methods. The study was conducted with 115 HF patients. “Sociodemographic characteristics form”, “Fear of COVID-19 tool” and “Nine-item European Heart Failure Self-care Behavior Scale (EHFScB Scale-9)” were used to collect data. Results. 51.3% of the participants in the study are in the 40–60 age range, 53.7% are male, 92.2% live with their family, 64.3% have a diagnosis of HF for less than 5 years. Levels of COVID-19 fear, and self-care management were found to be high in the participants who are 40 years old or younger, has higher education level, diagnosed within 1 to 3 years, received psychological support during the pandemic process, received training from doctor or nurse about COVID-19. Fear level and self-care levels were moderately positively correlated. Conclusion. During the COVID-19 pandemic, it is necessary to develop effective care strategies to identify individuals with diseases such as HF who should have high self-care management skills.
Źródło:: European Journal of Clinical and Experimental Medicine; 2024, 22, 2; 306-312
2544-2406
2544-1361
Pojawia się w:: European Journal of Clinical and Experimental Medicine
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Informacja

Wyszukujesz frazę "failure" wg kryterium: Temat

Źródło danych

Dostawca treści

Kolekcja

Rok wydania

Wydawca

Temat

Autor

Typ dokumentu

Język